Elanco Animal Health Inc Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Elanco Animal Health Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2024.
  • Elanco Animal Health Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $18M, unchanged year-over-year.
  • Elanco Animal Health Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $11M, a 22.2% increase year-over-year.
  • Elanco Animal Health Inc annual Income Tax Expense (Benefit) for 2023 was $36M, a 500% increase from 2022.
  • Elanco Animal Health Inc annual Income Tax Expense (Benefit) for 2022 was $6M.
  • Elanco Animal Health Inc annual Income Tax Expense (Benefit) for 2021 was -$88M, a 14.6% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $11M $18M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11M -$20M -$25M -500% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $36M $14M +$49M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$13M -$1M -$22M -105% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $9M $18M +$22M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$13M $5M -$19M -79.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $6M -$35M -$20M -133% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $26M $21M +$43M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$17M -$4M +$33M +89.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$50M $24M +$37M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$87M -$15M -$19.7M -419% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$67.3M -$22M +$52M +70.3% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 -$119M -$37M -$13M -54.2% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 -$106M -$13M +$6M +31.6% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 -$112M $4.7M -$500K -9.62% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$112M -$74M -$51.5M -229% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$60.3M -$24M -$38.3M -268% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$22M -$19M -$32.3M -243% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $10.3M $5.2M +$23.8M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$13.5M -$22.5M -$41.1M -221% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $27.6M $14.3M -$8.5M -37.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $36.1M $13.3M +$8.5M +177% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $27.6M -$18.6M -$24.7M -405% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $52.3M $18.6M +$7M +60.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 $45.3M $22.8M +$7.8M +52% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 $37.5M $4.8M -$40.6M -89.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 $78.1M $6.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 $11.6M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 $15M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 $45.4M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.